Chlamydia Treatment Market Size

Chlamydia Market size was valued at USD 3.07 billion in 2023 and is set to cross USD 8.97 billion by 2036, expanding at more than 8.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of chlamydia is evaluated at USD 3.28 billion. The growth of the market can be attributed to the increasing prevalence chlamydia and other sexually transmitted diseases, and rise in demand for screening of the disease among people all around the world. According to the World Health Organization, each year, there are an estimated 376 million new infections with 1 of 4 STIs: chlamydia, gonorrhea, syphilis and trichomoniasis. Also, more than 1 million sexually transmitted infections (STIs) are acquired every day worldwide. Along with these, growing number of government initiatives and free diagnostic camps for spreading awareness about sexually transmitted infections is also predicted to be a significant factor driving market growth in the near future. Furthermore, favorable reimbursement policies for companies are evaluated to give impetus to research and development activities associated with the development of novel drugs, which in turn is projected to offer lucrative opportunities for market growth in the forthcoming years.